MIT Sues Dharmacon Over Payments for RNA Interference-Related IP License

Feb 11, 2005

Premium

The Massachusetts Institute of Technology is suing Dharmacon for failing to pay sufficient royalties on the sale of its RNAi products, according to court documents obtained by RNAi News.

According to MIT’s lawsuit filed in the US District Court for the District of Massachusetts, the research institute in December 2001 granted Dharmacon co-exclusive rights to use its siRNA technology for internal research or to sell research reagents based on the technology for educational and research purposes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

How to Perform Successful CRISPR Experiments

High Throughput RT-qPCR for Gene Expression Analysis

Jun

19

Featured Webinar

RNA in situ Hybridization: The Next Generation of Immunohistochemistry?

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Main menu